On Monday, March 2, 2020, Dr. Stephen Hahn, the FDA's commissioner, explained that the agency had taken actions to allow non-public labs and corporations to start making their own personal coronavirus checks in order to considerably broaden the U.S. capability to check to the virus. Hahn went on